Journal Article

Effect of the “Normalized Epidemic Prevention and Control Requirements” on hospital-acquired and community-acquired infections in China

Chen, Caiyun, Liu, Bo, Zhang, Yongxiang, Zhu, Ping

2021

نظرة عامة

No studies have yet reported the effect of prevention and control measures, which were implemented to combat COVID-19, on the prevention and control of common HAIs. We aimed to examine the effect of the \"Normalized Epidemic Prevention and Control Requirements\" (implemented in May 2020) by comparison of hospital-acquired infections (HAIs) and community-acquired infections (CAIs) in China during 2018, 2019, and 2020. Data of inpatients before and after implementation of new requirements were retrospectively analyzed, including infection rate, use of alcohol-based hand cleaner, anatomical sites of infections, pathogen species, infection by multi-drug resistant species, and use of different antibiotics. The HAI rate was significantly higher in 2020 than in 2018 and 2019 (P < 0.05), and the CAI rate was significantly higher in 2019 and 2020 than in 2018 (P < 0.001). Lower respiratory tract infections were the most common HAI during all years, with no significant changes over time. Lower respiratory tract infections were also the most common CAI, but were significantly more common in 2018 and 2019 than 2020 (P < 0.001). There were no changes in upper respiratory tract infections among HAIs or CAIs. Most HAIs and CAIs were from Gram-negative bacteria, and the percentages of fungal infections were greater in 2019 and 2020 than 2018. MRSA infections were more common in 2020 than in 2018 and 2019 (P < 0.05). The utilization rate and usage days of antibiotics decreased over time (P < 0.001) and the culture rate of microbial specimens before antibiotic usage increased over time (P < 0.001). The new prevention and control requirements provided important benefits during the COVID-19 pandemic. However, their effects on HAIs were not obvious.

• الناشر: BioMed Central Ltd,BioMed Central,BMC
• موضوع: Antibiotics / Bacteria / China / Community-acquired infections / Comparative analysis / Control / Coronaviruses / COVID-19 / Cross infection / Disease control / Drug resistance / Epidemic prevention and control / Epidemics / Gram-negative bacteria / Health aspects / Hospital patients / Hospital-acquired infection / Hospitals / Infection control / Infections / Infectious sites / Laws, regulations and rules / Masks / Microorganisms / Multi-drug resistant organisms / Multidrug resistance / Mycoses / Normalized Epidemic Prevention and Control Requirements / Nosocomial infections / Pandemics / Prevention / Public health / Respiratory tract / Respiratory tract diseases / Safety and security measures / Staphylococcal infections / Staphylococcus infections / Statistics / Usage of antibiotics / Viral diseases